Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 3/20 | 0.71 |
| ▸ | CES1 | P23141 | 3/20 | 0.71 |
| ▸ | S100A4 | P26447 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 3/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
| ▸ | PTPRC | P08575 | 1/20 | 0.44 |
| ▸ | BCL2 | P10415 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.42 |
| ▸ | CDK1 | P06493 | 2/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.42 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28881913 | 1.00 | TGM2 (0.71) | TGM2CES1S100A4KMT2AMEN1 | |
| SCHEMBL15165815 | 0.86 | TGM2 (0.69) | TGM2CES1S100A4KMT2AMEN1 | |
| SCHEMBL29505404 | 0.83 | TGM2 (1.00) | TGM2CES1S100A4LRRK2AGTR1 | |
| SCHEMBL136581 | 0.83 | TGM2 (1.00) | TGM2CES1S100A4LRRK2AGTR1 | |
| SCHEMBL11920847 | 0.83 | CES1 (0.50) | TGM2CES1S100A4PTPRCBCL2 | |
| Water SCHEMBL8100148 | 0.82 | TGM2 (0.96) | TGM2CES1LRRK2AGTR1CA1 | |
| Methane SCHEMBL28522344 | 0.82 | TGM2 (0.96) | TGM2CES1LRRK2AGTR1CA1 | |
| SCHEMBL23752448 | 0.81 | TGM2 (0.61) | TGM2CES1LRRK2AGTR1PTPRC | |
| SCHEMBL3848773 | 0.81 | TGM2 (0.61) | TGM2CES1LRRK2AGTR1PTPRC | |
| SCHEMBL29194204 | 0.80 | TGM2 (0.67) | TGM2CES1S100A4KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10208186-B2 | Latex comprising colorant and methods of making the same | XEROX CORPORATION (US) | 2019-02-19 | — | — | US | disclosed |
| US-20170073499-A1 | LATEX COMPRISING COLORANT AND METHODS OF MAKING THE SAME | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2017-03-16 | — | — | US | disclosed |
| US-9580578-B2 | Latex comprising colorant and methods of making the same | XEROX CORPORATION (US) | 2017-02-28 | — | — | US | disclosed |
| US-20160024276-A1 | LATEX COMPRISING COLORANT AND METHODS OF MAKING THE SAME | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2016-01-28 | — | — | US | disclosed |
| US-9213248-B2 | Latex comprising colorant and methods of making the same | XEROX CORPORATION (US) | 2015-12-15 | — | — | US | disclosed |
| US-20150125888-A1 | ONE STEP ENZYMATIC PROCESS FOR PRODUCING ALKYL FURANOSIDES | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (ENSCR) (FR) | 2015-05-07 | — | — | US | disclosed |
| US-20150030977-A1 | LATEX COMPRISING COLORANT AND METHODS OF MAKING THE SAME | XEROX CORPORATION (US) | 2015-01-29 | — | — | US | disclosed |
| WO-2013160205-A1 | ONE STEP ENZYMATIC PROCESS FOR PRODUCING ALKYL FURANOSIDES | ÉCOLE NATIONALE SUPÉRIEURE DE CHIMIE DE RENNES (ENSCR) (FR) | 2013-10-31 | — | — | WO | disclosed |
| US-8551188-B2 | Composition comprising a hydrophobic dye, a particular organic and/or mineral alkaline agent, a particular compound (I) and a particular organic compound (II), and dyeing use thereof | L'OREAL (FR) | 2013-10-08 | — | — | US | disclosed |
| US-20120204357-A1 | COMPOSITION COMPRISING A HYDROPHOBIC DYE, A PARTICULAR ORGANIC AND/OR MINERAL ALKALINE AGENT, A PARTICULAR COMPOUND (I) AND A PARTICULAR ORGANIC COMPOUND (II), AND DYEING USE THEREOF | L'OREAL (FR) | 2012-08-16 | — | — | US | disclosed |
| WO-2011027076-A2 | DYEING METHOD CONSISTING IN APPLYING A METALLIC SALT AND A COMPOSITION CONTAINING A HYDROPHOBIC DYE AND A SPECIFIC COMPOUND | L'OREAL (FR) | 2011-03-10 | — | — | WO | disclosed |
| WO-2011027077-A2 | COMPOSITION COMPRISING A HYDROPHOBIC DYE, A SPECIFIC MINERAL AND/OR ORGANIC ALKALINE AGENT, A SPECIFIC COMPOUND (I) AND A SPECIFIC ORGANIC COMPOUND (II), AND USE THEREOF IN DYEING | L'OREAL (FR) | 2011-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120204357-A1 | COMPOSITION COMPRISING A HYDROPHOBIC DYE, A PARTICULAR ORGANIC AND/OR MINERAL ALKALINE AGENT, A PARTICULAR COMPOUND (I) AND A PARTICULAR ORGANIC COMPOUND (II), AND DYEING USE THEREOF | KRT18, DSG1, DSC1 | TGM2 2926/4885CES1 2796/4885S100A4 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.